Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Long-Term Debt : ¥1,214 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Tianjin Chase Sun Pharmaceutical Co Long-Term Debt?

Tianjin Chase Sun Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥1,214 Mil.

Tianjin Chase Sun Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2023 (¥1,484 Mil) to Dec. 2023 (¥1,257 Mil) and declined from Dec. 2023 (¥1,257 Mil) to Mar. 2024 (¥1,214 Mil).

Tianjin Chase Sun Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (¥1,458 Mil) to Dec. 2022 (¥1,345 Mil) and declined from Dec. 2022 (¥1,345 Mil) to Dec. 2023 (¥1,257 Mil).

Tianjin Chase Sun Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Tianjin Chase Sun Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Chase Sun Pharmaceutical Co Long-Term Debt Chart

Tianjin Chase Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

45.00

362.03

1,458.10

1,345.25

1,257.25

Tianjin Chase Sun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															1,452.49	1,468.02	1,484.11	1,257.25	1,213.69

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Tianjin Chase Sun Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No. 20, Quanfa Road, Tianjin Wuqing Development Area, Tianjin, CHN, 301700

Website

http://www.chasesun.cn

Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.

Executives

Yao Xiao Qing	Director
Chen Rui Qiang	Executives
Li Chun Xu	Executives
Lan Wu Jun	Directors, Directors, and Executives
Zheng Dan	Directors, executives
Zhang Kun	Executives
Gao Guo Wei	Executives
Shang Xiao Mei	Securities Affairs Representative
Sun Zhang Hai	Director
Wu Guang Ning	Supervisors
Wang Long	Executives
Liu Qiang	Supervisors
Ceng Guo Zhuang	Director
Su Bing Jun	Directors, executives
Nie Wei	Supervisors

Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Headlines

No Headlines